• AJMCAJMC
  • Center for Biosimilars
The Center for Biosimilars - Biosimilars, Health Economics & Insights
The Center for Biosimilars - Biosimilars, Health Economics & Insights
Business Practice
View MoreBusinessDevelopmentLegalPolicyPracticeRegulatory
News
All News
Product Approvals and Launches
Media
All Videos
Insights
Interviews
Peer Exchange
Podcasts
Stakeholder Summit
Compendia
Bone Health
Dermatology
Diabetes
Gastroenterology
Hematology
Immunology
Neurology
Oncology
Ophthalmology
Rare Disease
Respiratory
Rheumatology
Conferences
Conference Coverage
Conference Listing
CME/CE
Resources
Authors
Biosimilar Resources
Interactive Tools
Partners
Polls and Quizzes
Sponsored
WHEN CHOICE ARRIVES: Competition & Consequences
SubscribeBIOSIMILAR APPROVALS
  • About
  • Editorial
  • Contact
  • Advisory Board
  • Do Not Sell My Information
  • Terms & Conditions
  • Privacy Policy

© 2025 MJH Life Sciences and The Center for Biosimilars - Biosimilars, Health Economics & Insights. All rights reserved.

Advertisement
Business PracticeSee All >
  • Business
  • Development
  • Legal
  • Policy
  • Practice
  • Regulatory
  • About
  • Editorial
  • Contact
  • Advisory Board
  • Do Not Sell My Information
  • Terms & Conditions
  • Privacy Policy
  • MJHLS Brand Logo

© 2025 MJH Life Sciences™ and The Center for Biosimilars - Biosimilars, Health Economics & Insights. All rights reserved.

IGBA Annual Meeting

  1. home

IGBA Panelists Discuss the Global Reputation of Biosimilars, Generics

February 21st 2023

Article

Panelists at the annual meeting of the International Generic and Biosimilar Medicines Association (IGBA) offered insight into the current state of the global biosimilar and generic markets and why government agencies need to leverage these medicines to address challenges in the pharmaceutical space.

IGBA 2023: Dr Monique Mansoura Highlights the Intersection of Geopolitical Issues, Biopharma

February 19th 2023

Article

COVID-19 allowed governments to critically examine the biopharma space to increase access to vaccines, but there's still a way to go, according to Monique Mansoura, PhD, MBA, executive director of global health security and biotechnology at the MITRE Corporation, at the International Generic and Biosimilar Medicines Association’s annual meeting.

Advertisement
Advertisement